Simon Ondrejka MD

Simon is an independent consultant at Augencentrum Köln in Cologne, Germany.

He studied medicine at the LMU Munich, and also studied in South Africa, New Zealand, Slovakia and France.

He has published 6-year data for iTrack 250 ab interno canaloplasty (in collaboration with Norbert Koerber).

More recently, his iTrack Advance manuscript "The impact of interventional glaucoma with and without cataract surgery in early open-angle glaucoma: 24-month results with a new canaloplasty device" has been provisionally accepted for publication in the Journal of Current Glaucoma Practice.

Simon and the team at Augencentrum Köln were the first official site enrolled in the CATALYST Study, joining in 2022.